2004N-0559 - Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee
FDA Comment Number : EC78
Submitter : Dr. James Wood Date & Time: 02/07/2005 07:02:30
Organization : Harbor Hospital of Baltimore
Health Professional
Category :
Issue Areas/Comments
The COX2's have been a mainstay of my practise since released several yrs. ago. Like any med, risk/benefit is a major consideration when prescribing. The marked decrease of GI side effects and events and the one pill dosing are very attractive. Clarification of the true risk with these meds would be very helpful. I seems like a lot of hype without much substance at this time.